The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Is There a Benefit of Drug-Eluting Stents Rather than Bare Metal Stents in Large Coronary Artery Lesions?

큰 관상동맥 병변에서 약물방출스텐트는 비약물 금속스텐트보다 이점이 있는가?

  • Lee, Wang-Soo (Department of Internal Medicine, Chung-Ang University College of Medicine)
  • 이왕수 (중앙대학교 의과대학 내과학교실)
  • Published : 2011.06.01
⟨ Previous Next ⟩

Abstract

Drug-eluting stents (DES) are widely used rather than bare metal stents (BMS) in percutaneous coronary intervention (PCI) because DES have been shown to dramatically reduce restenosis and improve the rate of event free survival. Many clinical trials have been shown the advantages of DES over BMS in subset of small coronary artery diseases. There are, however, conflicting reports on the advantages of DES over BMS for larger coronary artery lesions. In this issue of the journal, Kim et al investigated the clinical outcomes between DES and BMS in large coronary artery diseases. In future, additional large, randomized, controlled, muticenter trials with new generation DES and intravascular ultrasound-guided PCI will be needed to define the clear role of DES on large coronary artery lesions.

Keywords

References

  1. Quizhpe AR, Feres F, de Ribamar Costa J Jr, et al. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. Am Heart J 2007;154:373-378. https://doi.org/10.1016/j.ahj.2007.04.027
  2. Kaiser C, Galatius S, Erne P, et al. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010;363: 2310-2319. https://doi.org/10.1056/NEJMoa1009406
  3. Kim WJ, Cho JH, Jung JH, et al. Clinical comparison of drug-eluting stents and bare metal stents in large coronary arteries. Korean J Med 2011;80:664-671.
  4. Brunner-La Rocca HP, Kaiser C, Pfisterer M, et al. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007;28: 719-725. https://doi.org/10.1093/eurheartj/ehl490
  5. Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, et al. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J 2009;30:16-24.
  6. Na JO, Kim JW, Choi CU, et al. Bare-metal stents versus drug-eluting stents in large ($\geq$3.5mm) single coronary artery: angiographic and clinical outcomes at 6 months. J Cardiol 2009; 54:108-114. https://doi.org/10.1016/j.jjcc.2009.05.004
  7. Kim HT, Nam CW, Hur SH, et al. Two-year clinical outcomes after large coronary stent (4.0 mm) placement: comparison of bare-metal stent versus drug-eluting stent. Clin Cardiol 2010;33: 620-625. https://doi.org/10.1002/clc.20781
  8. Sim DS, Jeong MH, Ahn Y, et al. Effectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction. J Korean Med Sci 2011;26:521-527. https://doi.org/10.3346/jkms.2011.26.4.521